Peter D. Sly

Peter D. Sly

MBBS & BMedSc; MD; DSc (Advanced)

Pulmonologist

Over 40 years of Experience

Male📍 South Brisbane

About of Peter D. Sly

Peter D. Sly is a pulmonologist based in South Brisbane, at 62 Graham St, South Brisbane, QLD 4101. He looks after people with breathing and lung-related health problems, from everyday issues like coughs and chest infections to longer-term lung conditions.


Over time, his work has covered care for both adults and children. That includes asthma in kids, long-lasting airway problems, and chest conditions that can flare up and then settle again. At times, he also supports people dealing with sleep and breathing problems, including central sleep apnoea.


Many patients see him for conditions where breathing can feel hard or uncomfortable, such as chronic obstructive pulmonary disease (COPD), bronchiectasis, and recurring bronchitis or pneumonia. He also helps with allergic and immune-related issues that can affect the lungs and the nose, like allergic rhinitis, food allergy, and grass allergy.


In complex cases, he has experience with rarer infections and lung challenges too. This can include things like severe viral respiratory infections, persistent bacterial infections, and other harder-to-manage conditions that need careful follow-up. There is also experience across some genetic and neuromuscular conditions where breathing muscles may be affected, including spinal muscular atrophy (SMA) types 1, 2, and 3, plus ataxia-telangiectasia.


Peter has more than 40 years of experience. That kind of time in the field matters. It means he understands how symptoms can change with age, illness, and treatment. It also means he is used to working through cases where the cause isn’t straightforward and where patients need a clear plan for what to do next.


His training includes MBBS and BMedSc from the University of Melbourne, and later a Master of Medicine (MD) from the University of Melbourne. He also completed a DSc (Advanced) through the University of Western Australia.


Alongside day-to-day clinical work, he has been involved in medical publications, and clinical trials. This helps keep his approach grounded in evidence, especially when treatments and best practice are still being studied and updated.


If you’re trying to make sense of ongoing breathing issues, or you need specialist support for a more complex respiratory problem, Peter Sly’s clinic in South Brisbane is set up for that kind of care.

Education

  • MBBS & BMedSc, University of Melbourne
  • MD, University of Melbourne
  • DSc (Advanced), University of Western Australia

Services & Conditions Treated

AsthmaCystic FibrosisStridorAsthma in ChildrenBronchiectasisBronchitisSpinal Muscular Atrophy (SMA)Ataxia-TelangiectasiaCampylobacter InfectionMalnutritionMuscle AtrophyParainfluenzaPneumoniaPrimary Lateral SclerosisPseudomonas Stutzeri InfectionsSpinal Muscular Atrophy Type 2Spinal Muscular Atrophy Type 3Allergic RhinitisAspergillosisAtopic DermatitisAutism Spectrum DisorderAvian InfluenzaCentral Sleep ApneaChronic Obstructive Pulmonary Disease (COPD)FluFood AllergyGrass AllergyHeavy Metal PoisoningHepatitis AObesityPulmonary EdemaRespiratory Syncytial Virus (RSV) InfectionSevere Acute Respiratory Syndrome (SARS)Spinal Muscular Atrophy Type 1Strep ThroatTelangiectasiaTetanusTyphoid FeverVitamin D Deficiency

Publications

5 total
Emergency department presentations related to asthma and allergic diseases in Central Queensland, Australia: a comparative analysis between First Nations Australians and Australians of other descents.

BMJ open • March 04, 2025

Desalegn Shifti, Mahmudul Al Imam, Diane Maresco Pennisi, Renarta Whitcombe, Peter Sly, Craig Munns, Rachel Peters, Gulam Khandaker, Jennifer Koplin

Objective: To examine the overall incidence rate and trends in emergency department (ED) presentations related to asthma and allergic diseases in regional Australia with a particular focus on First Nations Australians. Methods: A retrospective analysis of data from the Emergency Department Information System. Methods: This study used data from 12 public hospitals in Central Queensland, Australia, a region encompassing regional, rural and remote outback areas. Methods: A total of 813 112 ED presentations between 2018 and 2023. Methods: Asthma and allergic diseases were identified using the International Classification of Diseases-Tenth Revision-Australian Modification codes. Results: There were 13 273 asthma and allergic disease-related ED presentations, with an overall prevalence of 1.6% (95% CI 1.6, 1.7). There was a significantly higher incidence rate of asthma and allergic disease-related ED presentations among First Nations Australians at 177.5 per 10 000 person-years (95% CI 169.3, 186.0) compared with 98.9 per 10 000 person-years (95% CI 97.2, 100.8) among Australians of other descents. The incidence rates, with corresponding 95% CIs, of the four most common cases among First Nations Australians and Australians of other descents, respectively, were as follows: asthma (87.8 (82.0, 93.8) and 40.2 (39.0, 41.3)), unspecified allergy (55.3 (50.8, 60.2) and 36.0 (34.9, 37.1)), atopic/allergic contact dermatitis (17.1 (14.6, 19.9) and 10.6 (10.0, 11.2)) and anaphylaxis (7.2 (5.6, 9.1) and 6.2 (5.7, 6.6)). Conclusions: Our findings highlight a significantly higher rate of asthma and allergic disease-related ED presentations among First Nations Australians compared with Australians of other descents. This underscores the urgent need for targeted healthcare interventions integrating culturally appropriate approaches, alongside additional research to understand causality.

Early-life allergic sensitization and respiratory infection-Two hits on lung function?

Journal: Pediatric Allergy And Immunology : Official Publication Of The European Society Of Pediatric Allergy And Immunology • March 19, 2025

Vikas Wadhwa, Shyamali Dharmage, Danielle Wurzel, Peter Sly, Cecilie Svanes, Adrian Lowe, N Idrose, Nilakshi Waidyatillake, Caroline Lodge, Melissa Russell

Background: Allergic sensitization and respiratory infections commonly occur in childhood. Interplay between them in asthma development is known as the 'two-hit' hypothesis. There has been no previous investigation of this hypothesis on adult lung function. Objective: In a birth cohort at high risk for allergic diseases, we investigated interactions between these two factors and lung function outcomes into adulthood. Methods: Allergic sensitization was assessed at age 24 months by skin prick testing to aero and food allergens. Respiratory infection was defined as cough, rattle or wheeze measured by frequent questionnaires up to age 24 months. Regression models were utilized to identify interactions between these exposures and associations with lung function at ages 12, 18 and 25 years. Results: At age 25 years, those sensitized at age 2 years(n = 118) demonstrated reductions in pre-bronchodilator FEV1 of 0.06(95% CI: -0.12, 0.00, z-score units, p = .055) for each additional month of respiratory infections. Those not sensitized (n = 120) had increases in pre-bronchodilator FEV1 of 0.07 (95% CI: 0.02, 0.13, z-score units, p = .012) for each additional month of respiratory infection(pinteraction = .012). Similar findings were noted for FEV1/FVC ratio(pinteraction = .011), FEF25-75(pinteraction = .007) and absolute change in pre and post bronchodilator lung function. At 18 years, findings were similar; however, there was less evidence for interactions at 12 years. Conclusions: Our study findings support the 'two-hit' hypothesis of interactions between early-life allergic sensitization and increasing respiratory infections, and impairment in lung function up to age 25 years. Early childhood respiratory infections however had different impacts on lung function depending upon the presence or absence of allergic sensitization.

Associations between household characteristics and environmentally persistent free radicals in house dust from two Australian locations.

Frontiers In Public Health • March 31, 2025

Wen Lee, Prakash Dangal, Gaurav Langan, Nina Lazarevic, Zhiwei Xu, Stephania Cormier, Slawo Lomnicki, Peter Sly, Dwan Vilcins

The association between air pollution and adverse health outcomes has been extensively documented, with oxidative stress widely considered a contributing factor. However, the precise underlying mechanism(s) remains unclear. Recent studies suggest that environmentally persistent free radicals (EPFRs) may provide the missing connection between air pollution and its detrimental health effects. Nevertheless, the indoor environment has received limited attention in EPFR research. Therefore, in this study, we measured EPFRs in house dust samples from two locations in Australia and examined household characteristics associated with their presence. Household characteristics and behaviours that influence indoor air quality were collected from an online questionnaire; 24-h indoor and outdoor air quality were measured with a TSI DustTrak™ DRX Aerosol monitor 8,533; annual indoor and outdoor air quality were matched to two validated, satellite-based land-use regression models; and dust samples were collected from house vacuums. Dust samples were analyzed using nano electron paramagnetic resonance (EPR) to determine spin concentrations, g-factor, and delta H peak-to-peak (Hp-p). Key variables were identified using Lasso-penalized regression models, followed by unpenalized linear regression and post-selection inference to estimate coefficients and assess the robustness of the findings. Our analysis revealed that factors such as extractor fan usage during cooking, exposure to traffic-related air pollution and ambient PM2.5 levels, indoor combustion activities, seasonal variation, housing construction type, ventilation, and cleaning practices were significantly associated with EPFR concentrations in Australian homes. Notably, consistent use of extractor fans during cooking was strongly and consistently associated with lower EPFR concentrations in house dust across both study locations. Our research provided insight into the potential impact of household characteristics on EPFR concentrations, which can potentially lead to adverse health effects. Future research should link our research findings on factors affecting indoor EPFRs to their potential health effects.

Phthalates and bisphenols early-life exposure, and childhood allergic conditions: a pooled analysis of cohort studies.

Journal Of Exposure Science & Environmental Epidemiology • May 07, 2025

Thomas Boissiere O'neill, Nina Lazarevic, Peter Sly, Anne-louise Ponsonby, Aimin Chen, Meghan Azad, Joseph Braun, Jeffrey Brook, David Burgner, Bruce Lanphear, Theo Moraes, Richard Saffery, Padmaja Subbarao, Stuart Turvey, Kimberly Yolton

Background: Exposure to plastic additives, such as phthalates and bisphenols, has been associated with a higher risk of allergic conditions, but the evidence is inconsistent for children younger than five. Objective: To examine the association between pre- and postnatal urinary phthalates and bisphenols, and allergic conditions, and potential effect modification by sex, in pre-school children, through a pooled analysis. Methods: We pooled data from the Barwon Infant Study (Australia), the Canadian Healthy Infant Longitudinal Development Study (Canada), the Health Outcomes and Measures of the Environment (United States) and the Environmental Influences on Child Health Outcomes-wide cohorts (United States). Urinary phthalates and bisphenols were measured during pregnancy and early childhood. We estimated daily intakes from urinary concentrations, except for mono-(3-carboxypropyl) phthalate (MCPP). Outcomes, including asthma, wheeze, eczema, and rhinitis, were assessed up to five years of age through questionnaires and clinical assessments. We used generalised estimating equations for single compounds and quantile G-computation for the chemical mixtures. Results: 5306 children were included. A two-fold increase in prenatal dibutyl phthalates (DBP; risk ratio [RR] = 1.08; 95% confidence interval [CI]: 1.00-1.16) and benzyl butyl phthalate (BBzP; RR = 1.06; 95%CI: 1.00-1.12) increased the risk of asthma in children under five. Prenatal MCPP levels were associated with rhinitis (RR = 1.05; 95%CI: 1.01-1.09). Postnatal BBzP levels increased the risk of wheezing (RR = 1.05; 95%CI 1.01-1.09), as well as di(2-ethylhexyl) phthalate (DEHP; RR = 1.06; 95%CI: 1.01-1.11) and MCPP (RR = 1.09; 95%CI: 1.04-1.14). These were also inversely associated with eczema. A one-quartile increase in the postnatal chemical mixture increased the risk of wheezing (RR = 1.14; 95%CI: 1.02-1.26). There was limited evidence of effect modification by sex. Conclusions: Phthalates and bisphenols are widespread and may contribute to allergic conditions in children. We pooled data from 5000 children across multiple birth cohorts, suggesting that early-life exposure to these chemicals is associated with increased risks of asthma, wheezing, and rhinitis by age five. We further investigated the timing of exposure, non-linear dose-response relationships, and effect measure modification by sex. This study provides a comprehensive assessment of early-life exposure to phthalates and bisphenols and strengthens the evidence for their role in the development of childhood allergic outcomes.

Phthalates, bisphenols and per-and polyfluoroalkyl substances migration from food packaging into food: a systematic review.

Reviews On Environmental Health • February 16, 2025

Madeline Tanzer, Thomas Boissiere O'neill, Peter Sly, Dwan Vilcins

Endocrine-disrupting chemicals are commonly found in food due to their migration from plastic packaging. Despite their functional benefits, these additives can disrupt the endocrine system, leading to several adverse health outcomes. This review aims to examine the migration of phthalates, bisphenols, and per-and-polyfluoroalkyl substances (PFAS) from plastic food packaging into food substances. Six electronic databases were systematically screened for observational, case reports, or experimental studies investigating any food for human consumption exposed to food packaging. Sixty-seven studies, including 5,378 samples, were included. Phthalates and bisphenols consistently migrated from food packaging. PFAS migration was also detected but too few studies were published to draw conclusions. Migration rates were influenced by factors such as temperature, exposure time, and food composition, with high-fat or acidic foods leading to higher migration rates. Based on a standard Western Diet, 713.8 µg of di-2-ethylhexyl phthalate, 347.7 µg of di-n-butyl phthalate, 17.3 µg of butyl-benzyl phthalate, 35,250 µg of di-iso-decyl phthalate, and 65.4 µg of other plasticizers, totaling 36,349.2 µg, could be consumed from food packaging daily. However, these estimates may not be generalizable to other dietary patterns, such as Mediterranean or plant-based diets. Further research into low migration or safer alternative to current plasticizers, alongside regulatory efforts considering potential exposure via food contact materials may help reduce risks associated with endocrine-disrupting chemicals in food packaging.

Clinical Trials

1 total

A Phase 2A/2B Placebo-controlled Randomised Clinical Trial to Test the Ability of Triheptanoin to Protect Primary Airway Epithelial Cells Obtained From Participants With Ataxia-telangiectasia Against Death Induced by Glucose Deprivation

CompletedPhase 2

Study design: Parallel group, placebo-controlled, dose-escalation each 2 months for 12 months. Dose based on percent (%) of calculated caloric intake. Thirty participants will be randomised in blocks on a 1:1:1 ratio into one of three groups stratified by age (\< 5 years, 5-10 years, \> 10 years of age). Group 1: 10%, 20%, 35%, 35%, 35% (no placebo). Group 2: placebo, 10%, 20%, 35%, 35% Group 3: placebo, placebo, 10%, 20%, 35%. Primary endpoint: The percent cell death induced by glucose deprivation in cell culture. Secondary endpoints include: Scales for assessment and rating of ataxia, International Cooperative Ataxia Rating Scale, Ataxia Telangiectasia Neurological Examination Scale Toolkit, speech and language assessment, EyeSeeCam assessment, MRI lung imaging, Lung function, Upper respiratory microbiome, Faecal microbiome, Survival and inflammatory phenotype of airway epithelial cells, macrophages and in serum, Metabolomic biomarker discovery in serum and measurement of neuroflament light chain.

Participants: 30

Frequently Asked Questions

What services does Dr Peter D. Sly offer?
Dr Sly provides a wide range of pulmonary care. Services include treatment for asthma, COPD, pneumonia, bronchitis, sleep-related breathing issues, and various lung conditions. He also cares for children with asthma and other respiratory concerns.
Where is Dr Peter D. Sly’s clinic located?
His practice is at 62 Graham St, South Brisbane, QLD 4101, Australia.
How can I book an appointment?
Appointments can be arranged through the clinic’s reception. If you’re not sure what you need, you can call ahead to discuss your symptoms and we can help set up the right visit.
What conditions does he commonly treat?
He treats a range of lung and breathing issues, including asthma, COPD, pneumonia, bronchitis, allergic rhinitis, sleep-related breathing problems, and rare or complex pulmonary conditions as part of managing long-standing respiratory health.
Does he treat children or only adults?
Dr Sly cares for patients across ages, including children with asthma and other respiratory concerns.
What should I bring to my appointment?
Bring any previous medical records, current medications, and details about your breathing symptoms or lung tests. If you have recent imaging or test results, bring those as well.

Contact Information

62 Graham St, South Brisbane, QLD 4101, Australia

Is this your profile?

Claim this profile →